Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 40.00
+0.40 (1.01%)
Oct 23, 2026, 4:25 PM CEST
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 618.34 million as of October 23, 2026. It is the 28,046th most valuable company in the world and the 196th biggest in Norway. Its market cap has decreased by 27.10% in one year.
Market Cap
618.34M
Enterprise Value
542.88M
Revenue
191.35M
Global Rank
Country Rank
#196 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 618.34M, an increase of 113.50%. That is a compound annual growth rate of 7.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 618.34M | -28.91% |
| Dec 30, 2025 | 869.82M | 43.88% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 5.49B |
| Circio Holding ASA | 3.16B |
| Nordhealth AS | 2.11B |
| Thor Medical ASA | 1.77B |
| Nykode Therapeutics AS | 1.03B |
| Omda AS | 912.59M |
| Vistin Pharma ASA | 813.72M |
| INIFY Laboratories AB | 644.85M |